Inflammatix
Inflammatix, Inc., based in Sunnyvale, California, USA, is redefining molecular diagnostics by leveraging machine learning and host-response biology to generate accurate, actionable results. Backed by leading healthcare investors and federal support, the company aims to improve outcomes and lower costs through faster, smarter testing.
Content by Inflammatix
|4 min read
Breakthrough Sepsis Test Could Save Lives and Billions by Catching the Infection Early
Inflammatix cracks the code of sepsis with an AI-powered test that outperforms the standard of carePage 1 of 1
